
Chris Aug
A Master of Pharmacy w/diverse experience in Pharmaceutical and Biotechnology Sales, Marketing, Medical/Scientific Affairs, Business Development & Manufacturing/Operations.... | United States
*50 free lookup(s) per month.
No credit card required.
Chris Aug’s Emails ca****@ja****.com
Chris Aug’s Phone Numbers 1609730****
Social Media
Chris Aug’s Location United States
Chris Aug’s Expertise A Master of Pharmacy w/diverse experience in Pharmaceutical and Biotechnology Sales, Marketing, Medical/Scientific Affairs, Business Development & Manufacturing/Operations. Combining business acumen w/strong scientific and technical skills. Diverse roles across disciplines (National Director Clinical Affairs, Director/Brand Lead Marketing, Project Management, R&D and Medical/Scientific Affairs Manager) in multiple therapeutic categories (Oncology, Cardiovascular, Neurology/CNS, HIV/Virology & Hemophilia). Combined experience provides a unique perspective and approach to collaboration across businesses to ensure optimal success of a product or portfolio. Has led or played key role in ~10 new product launches, line-extensions/new indications (Global & U.S.). Extensive skill set includes project management, cross-functional team leadership, brand marketing, payer marketing (reimbursement & formulary access) and medical communications. As Director Business Development, played a pivotal role in FDA PMA 501(k), CLIA Waiver and the commercialization and launch of Alere (Abbott’s) ‘Determine Combo’ diagnostic test. Prior, as Associate Director of Marketing w/Boehringer-Ingelheim, was global brand lead responsible for HIV franchise and the launch of Viramune XR. Also led in development of brand planning, positioning, strategy & messaging (developing global messaging & brand book) and tactical plan. Created innovative & award winning HCP, Consumer, Pharmacy & Managed Markets strategies/tactical plans driven by advisory boards and market research. An experienced Medical Education Marketer (Medical/Scientific information/communication), responsible for Key Opinion Leader development, speaker programs & clinical investigator meetings. Experienced in all phases of life cycle management from launch through loss of exclusivity. Has managed in-line and global products and portfolios and has been integral in multiple international product launches in countries such as Canada, Spain, Italy, Germany, U.K., Japan and Australia. Since 2021 he has been supporting J&J in the early development and expansion of a national field-based team to support the launch of cutting edge Cell Therapy (CAR-T) technology ‘CARVYKTI’ in hematology.
Chris Aug’s Current Industry Johnson And Johnson Innovative Medicine
Chris
Aug’s Prior Industry
Dupont Pharmaceuticals
|
Pfizer
|
Agouron Pharmaceuticals
|
Agouron Pfizer
|
The Jl
|
Baxter Bioscience
|
Boehringer Ingelheim Pharmaceuticals
|
The Falk
|
Alere
|
The Janssen Pharmaceutical Companies Of Johnson And Johnson
|
Johnson And Johnson Innovative Medicine
Not the Chris Aug you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Johnson And Johnson Innovative Medicine
Cell Therapy Experience Lead (NYC/Northeast)
Sat Jun 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
The Janssen Pharmaceutical Companies Of Johnson And Johnson
Oncology Specialist (Hematologic Malignancies) CAR-T Cell Therapy, Northeast U.S.
Wed Sep 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
The Janssen Pharmaceutical Companies Of Johnson And Johnson
Executive Sales Specialist, Oncology (#1 of 104 in 2018)
Sat Apr 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
The Janssen Pharmaceutical Companies Of Johnson And Johnson
Executive Area Business Specialist (CNS/Neurology) [#3 of 235 2016]
Wed Apr 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Apr 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Alere
Director of Clinical & Business Development
Sat Jun 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
The Falk
Director, Business Development (Consultant)
Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jun 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Boehringer Ingelheim Pharmaceuticals
Associate Director, Marketing
Mon Jan 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Apr 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Baxter Bioscience
Sr. Manager
Mon Nov 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Dec 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
The Jl
V.P./Account Manager
Sat Nov 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Nov 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Agouron Pfizer
Sr. Product Manager
Sat May 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Nov 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Pfizer
PSL (Field-based Professional Science Liaison), Manager (Mktg), Sr. Manager (Mktg),
Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Agouron Pharmaceuticals
Professional Science Liaison
Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Dupont Pharmaceuticals
Specialty Sales Representative
Thu May 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat May 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time)
Dupont Pharmaceuticals
Scientist (DMPK)/Project Management
Mon May 01 1995 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu May 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time)
Dupont Pharmaceuticals
Master Scheduler/Production Planner
Fri May 01 1992 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon May 01 1995 00:00:00 GMT+0000 (Coordinated Universal Time)